What is ENOUGH?
ENOUGH is a pioneering biotech firm established in 2015, headquartered in Glasgow, Scotland. The company specializes in leveraging natural biological processes to produce high-quality protein derived from fungi. Their core mission is to develop sustainable, plant-based protein alternatives that closely mimic the taste and texture of animal proteins, addressing the growing global demand for environmentally conscious food solutions.
How much funding has ENOUGH raised?
ENOUGH has raised a total of $43.5M across 1 funding round:
Other Financing Round
$43.5M
Other Financing Round (2023): $43.5M with participation from HAL Investments, CPT Capital, and World Fund
Key Investors in ENOUGH
HAL Investments
HAL Investments is the Dutch investment subsidiary of HAL Holding N.V., focusing on acquiring significant shareholdings in various companies to enhance long-term shareholder value. With a diverse portfolio of internationally active companies, HAL manages a net asset value of 15.5 billion as of December 31, 2024. The company has a rich history dating back to 1873 and transitioned from shipping activities to investment in 1989. HAL targets both listed and non-listed companies across a wide range of industries, primarily in the Netherlands and internationally.
CPT Capital
CPT Capital is an investment firm focused on the future of food and materials, specifically in the alternative protein sector. They partner with visionary founders and companies that utilize cutting-edge technologies to replace animals in the supply chain. Their portfolio includes innovative firms like Impossible Foods and Beyond Meat, which challenge traditional food systems through plant-based and cultivated protein solutions. With extensive experience in the industry, CPT Capital aims to drive the food technology revolution by supporting the development of sustainable protein alternatives.
World Fund
World Fund is a leading European venture capital fund that invests in entrepreneurs developing climate technology capable of reducing at least 100 million tons of CO2e emissions annually. The fund supports startups from Seed to Series B stages, focusing on those with significant climate performance potential. Their portfolio includes innovative companies in various sectors, such as sustainable food, battery recycling, and renewable energy. World Fund aims to foster a regenerative world through investments that prioritize decarbonization and social equity.
What's next for ENOUGH?
The substantial enterprise-level funding, particularly the recent strategic investment, positions ENOUGH for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development, scale production capabilities, and enhance market penetration for their innovative fungal protein. The company's focus on sustainability and its ability to replicate animal protein characteristics suggest a strong trajectory in the competitive alternative protein landscape.
See full ENOUGH company page
